Cost-Effectiveness Analysis of Fecal Immunochemical Test-based Versus Total Colonoscopy-Based Colorectal Cancer

Taichi Mori1, Nobuyuki Shimohata2, Rei Goto3

  • 1Graduate School of Health Management, Keio University, Tokyo, Japan.

Summary

In Japan, fecal immunochemical tests (FIT) are more cost-effective for colorectal cancer screening than total colonoscopy (TCS). Improving FIT participation offers greater public health benefits than switching to TCS.